What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey

OBJECTIVE: Following a switch from either a generic or branded antidepressant (venlafaxine) to a new generic, we investigated the factors associated with a preference for branded medicines, side effects reported following switching and efficacy ratings of the new generic drug. DESIGN: A cross-sectio...

Descripción completa

Detalles Bibliográficos
Autores principales: MacKrill, Kate, Petrie, Keith J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196872/
https://www.ncbi.nlm.nih.gov/pubmed/30341138
http://dx.doi.org/10.1136/bmjopen-2018-023667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196872/
https://www.ncbi.nlm.nih.gov/pubmed/30341138
http://dx.doi.org/10.1136/bmjopen-2018-023667

Ejemplares similares